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Treatment of wild-type vaccinia virus infected cells with the anti-poxviral drug isatin-β-thiosemicarbazone (IBT) induces the viral postreplicative
transcription apparatus to synthesize longer-than-normal mRNAs through an unknown mechanism. Prior studies have shown that virus mutants
resistant to or dependent on IBT affect proteins involved in control of viral postreplicative transcription elongation, including G2, J3, and the viral
RNA polymerase. Prior studies also suggest that there exist additional unidentified vaccinia genes that influence transcription elongation. The present
study was undertaken to target candidate transcription elongation factor genes in an error-prone mutagenesis protocol to determine whether IBT-
resistant or -dependent alleles could be isolated in those candidate genes. Mutagenesis of genes in which IBT resistance alleles have previously been
isolated, namely A24R (encoding the second largest RNA polymerase subunit, rpo132) and G2R (encoding a positive transcription elongation
factor), resulted in isolation of novel IBT resistance and dependence alleles therefore providing proof of principle of the targeted mutagenesis
technique. The vaccinia H5 protein has been implicated previously in transcription elongation by virtue of its association with the positive elongation
factor G2. Mutagenesis of the vacciniaH5R gene resulted in a novelH5R IBT resistance allele, strongly suggesting that H5 is a positive transcription
elongation factor.
© 2007 Elsevier Inc. All rights reserved.Keywords: Vaccinia virus; Genetics; Drug resistance; Isatin-β-thiosemicarbazone; Transcription; RNA polymerase; Marker rescueIntroduction
Several vaccinia genes have been identified that control
postreplicative vaccinia transcription elongation and/or mRNA
3′ end formation (Condit and Niles, 2002) (see companion
manuscript for a more detailed summary of vaccinia post-
replicative gene transcription and its control; Cresawn et al.,
2007). These genes include A18R, which encodes a negative
transcription elongation factor, and G2R and J3R, which
encode positive transcription elongation factors (Black and
Condit, 1996; Xiang et al., 1998; Latner et al., 2000). In
addition, viral RNA polymerase mutants have been isolated⁎ Corresponding author.
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doi:10.1016/j.virol.2007.02.016that are altered in their elongation properties in a fashion that
impacts on late transcription (Condit et al., 1991; Prins et al.,
2004; Cresawn et al., 2007). Lastly, the product of the vaccinia
gene H5R is also implicated in postreplicative gene transcrip-
tion elongation by virtue of its association with the G2 protein
(Black et al., 1998).
Identification of genes that influence vaccinia postreplicative
gene transcription has been aided significantly by isolation and
characterization of virus mutants that are dependent upon or
resistant to the antipoxviral drug, isatin-β-thiosemicarbazone
(IBT). Although the precise mechanism of action of IBT is un-
known, addition of the drug to wild-type vaccinia virus infec-
tions results in synthesis of postreplicative mRNA transcripts
that are longer than normal, presumably because of enhanced
transcription elongation or inhibition of transcription termina-
tion (Bayliss and Condit, 1993; Xiang, 1998). IBT-dependent
mutants have been isolated in the positive transcription
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have been isolated in genesG2R, J3R, and in the genes encoding
the largest two subunits of the viral RNA polymerase, rpo147
(J6R) and rpo132 (A24R) (Condit et al., 1991; Meis and Condit,
1991; Hassett and Condit, 1994; Condit et al., 1996; Latner et al.,
2000; Cresawn et al., 2007). G2R and J3Rmutants that are IBT-
dependent synthesize severely 3′ truncated and therefore
nonfunctional postreplicative RNAs, preventing virus growth
in the absence of drug; addition of IBT to cells infected with
dependent mutants promotes extension of the postreplicative
viral mRNA 3′ ends to restore functionality to the RNAs and
growth of the virus (Black and Condit, 1996; Latner et al., 2000).
The molecular defect in IBT-resistant mutants is more subtle. IBT-
resistant RNA polymerase mutants are defective in transcription
elongation in vitro, and we believe that in vivo, IBT-resistant
mutants synthesize slightly shorter than normal postreplicative
RNAs, thus compensating for the elongation-promoting effects of
IBT (Condit et al., 1991; Hassett and Condit, 1994; Latner et al.,
2002; Cresawn et al., 2007).
To date, genes which modify the response of vaccinia to IBT
have been identified primarily by genetic characterization of
spontaneous IBT-resistant or -dependent mutants. While this
effort has been informative, it ultimately approaches a point of
diminishing returns since the majority of mutants isolated map to
genes that are particularly susceptible to mutation to IBT re-
sistance or dependence. However, the catalogue of factors that
influence vaccinia posttranscriptional elongation is probably
incomplete. IBT-resistant mutants have been isolated which are
recalcitrant to genetic mapping yet do not affect the known
elongation factors (Cresawn et al., 2007), and additional
vaccinia proteins have been identified, for example H5, which
are implicated in transcription elongation by virtue of associa-
tion with elongation factors, but have not been proven to
influence elongation in vivo using genetic criteria (Black et al.,
1998). Therefore, in an attempt to expand the catalogue of
elongation factors and probe the involvement of additional genes
in transcription elongation, we have used targeted mutagenesis
to determine whether IBT-resistant mutants can be isolated in
specific candidate elongation factor genes. We present here
proof of principle for the targeted approach by isolation of new
IBT resistance alleles in previously identified genes and
evidence that the H5R gene product plays a role in postrepli-
cative gene transcription.
Results
Isolation of novel IBT-resistant mutants using error-prone PCR
Error-prone PCR and marker rescue in the presence of IBT
were combined to screen several genes for possible roles inFig. 1. Targeted mutagenesis and selection for IBT resistance. (A) A diagram show
amplified from the A24R gene. (B) Marker rescue with error-prone PCR fragments. C
wild-type genomic DNA and the indicated PCR product. Controls are shown in the t
infected with Dts38 but not transfected. “WT genome” was infected with Dts38 and tr
panels, the top row contains negative controls, transfected with the indicated high-f
indicated error-prone PCR product. After a 4 day incubation at 37 °C in the presencintermediate and late transcription elongation. In this experi-
ment, cells were infected with the temperature-sensitive Dts38
helper virus, co-transfected with wild-type genomic DNA and a
PCR product corresponding to an open reading frame to be
tested, and incubated at 37 °C in the presence of IBT. These
conditions select against growth of wild-type or helper virus, and
select for IBT-resistant viruses formed by recombination of
mutations from the transfected PCR product into the co-
transfected wild-type genomic DNA (Cresawn et al., 2007).
The PCR product was generated in both a high-fidelity PCR
protocol (control) and an error-prone PCR protocol (experi-
mental). A positive result in this experiment was indicated by a
higher number of plaques on cells transfected with the error-
prone PCR product compared to cells transfected with the high-
fidelity PCR product from the same gene.
The G2R, J3R and A24R genes were tested in the error-prone
PCR and marker rescue protocol as positive controls. The G2R
and J3R genes were expected to produce the strongest signal,
because any mutation that inactivates either gene results in an
IBT dependence phenotype (Meis and Condit, 1991; Latner et
al., 2000) and therefore should produce a virus capable of
growing in the presence of IBT. The A24R gene, which encodes
the second largest subunit of the viral RNA polymerase, rpo132,
served as a more stringent positive control. Previous mapping of
IBTr90 to rpo132 indicated that it should be possible to construct
an IBT-resistant mutant in A24R (Condit et al., 1991). Pre-
liminary experiments indicated that the efficiency of amplifica-
tion of sequences longer than about 2 kbp was decreased in the
error-prone PCR format. For this reason, A24R was divided into
three overlapping segments ranging from 1.2 kbp to 1.5 kbp in
length, designated A24R-1, A24R-2, and A24R-3 from the 5′ to
3′ end (Fig. 1A). A pilot experiment (not shown) indicated that
the 5′-most fragment was the least likely to produce a signal and
therefore it was not included in further experiments.
The genes chosen as candidates for targeted mutagenesis to
IBT resistance were several with known roles in RNA binding or
synthesis. These included six RNA polymerase subunits (rpo7
[G5.5R], rpo18 [D7R], rpo19 [A5R], rpo22 [J4R], rpo30 [E4L]
and rpo35 [A29R]), the dsRNA-binding protein (E3L), the
intermediate transcription initiation factors (VITF-1 [E4L] and
VITF3 [A8R+A23R]), the late transcription initiation factors
(VLTF-1 [G8R], VLTF-2 [A1L], and VLTF3 [A2L]), and the late
transcription stimulatory factor (VLTF-4 [H5R]).
Results from the error-prone PCR and marker rescue
experiment are shown in Fig. 1B. As expected, the strongest
signal detected in this experiment was with the G2R or J3R
genes. However, a clear signal over background was also ob-
served with A24R-2, A24R-3, and rpo19 (A5R). Weaker signals
over background were observed with a number of other genes,
including E3L, A8R, and A23R (VITF-3), H5R (VLTF-4), A1Ling the three overlapping fragments, A24R-1, A24R-2, and A24R-3, that were
onfluent dishes of BSC40 cells were infected with Dts38 and co-transfected with
op row: “Uninfected” was neither infected nor transfected. “Untransfected” was
ansfected with wild-type genomic DNA alone. In each of the bottom three boxed
idelity PCR product, while the bottom row contains dishes transfected with the
e of IBT, dishes were stained with crystal violet.
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after mutagenesis and transfection of G2R and J3R indicates
that the error-prone PCR indeed induces IBT resistance muta-
tions that can be efficiently incorporated into the vaccinia
genome using the marker rescue and selection protocol des-
cribed. Therefore these positive controls, plus the stringent po-
sitive control, rpo132 (A24R), and several of the test genes were
analyzed further.
To determine whether plaques formed on the dishes trans-
fected with error-prone PCR products arose as a result of errors
in those PCR products, two plaques were picked for study from
each of the G2R, A24R-2, and A24R-3 dishes from an agar-
overlaid experiment otherwise identical to the one shown in Fig.
1. The resulting presumptive G2R mutant viruses were named
G2R-R1 and G2R-D1; one presumptive A24R mutant virus
resulting from mutagenesis of the A24R-2 DNA fragment was
named A24R-R1, and one presumptive A24R mutant virus
resulting from mutagenesis of the A24R-3 fragment was named
A24R-R2. The viruses in these plaques were plaque purified to
ensure that no contaminating helper virus was present and that
the stocks were genetically homogeneous. The plaque purified
viruses were grown, and viral DNA was then extracted from
lysates for use as a PCR template. The gene or gene fragment
targeted in the original error-prone PCR experiment, G2R,
A24R-2 or A24R-3, was PCR amplified from each mutant using
the high-fidelity protocol for use in a marker-rescue experiment.
In the case of the A24R-targeted mutants, the other two
fragments of the A24R gene were also amplified to ensure that
they did not contain mutations. The results are shown in Fig. 2.
Transfections using high fidelity PCR fragments representingFig. 2.G2R and A24Rmutants constructed by error-prone PCR mutagenesis map to th
with the Dts38 helper virus and co-transfected with wild-type genomic DNA (“WT g
presence of IBT, dishes were stained with crystal violet.G2R or A24R amplified from wild-type DNA templates yielded
a background level of plaque formation (Fig. 2, middle row,
“WT G2R”, “WT A24R-1”, “WT A24R-2”, “WT A24R-3”).
Transfections using high fidelity PCR fragments amplified from
the presumptive G2R mutants G2R-R1 and G2R-R2 yielded a
significantly higher number of plaques compared to control WT
G2R background (Fig. 2, compare “G2R-R1 G2R” and “G2R-
D1 G2R” with “WT G2R”). Likewise, when the A24R-2 or
A24R-3 regions of theA24R genewere targeted for mutagenesis,
the appropriate fragments amplified from the reconstructed
mutants rescued IBT resistance into WT virus in the infection/
transfection experiment (compare dishes “A24R-R1 A24R-2”
with “WTA24R-2” and “A24R-R2 A24R-3” with “WTA24R-
3”), whereas the untargeted fragments did not (compare “A24R-
R1 A24R-1” or “A24R-R1 A24R-3” with “A24R-R1 A24R-2”
and “A24R-R2 A24R-1” or “A24R-R2 A24R-2” with “A24R-
R2 A24R-3”). In summary, this experiment proves that the error-
prone PCR did indeed result in mutation of the targeted fragment
to create an IBT resistance allele.
To analyze the genotype of the G2R and A24R mutants, the
targeted gene in each mutant was sequenced. The results are
shown in Table 1. Sequencing the G2R-targeted mutants re-
vealed a single missense mutation of the G2R gene of G2R-R1
and a frameshift in G2R-D1. G2R-D1 contains a second down-
stream mutation which would encode a missense substitution in
the native protein, but is rendered irrelevant because of the
upstream frameshift. Sequencing of the A24R-targeted mutants
revealed a single missense mutation in each virus in the
appropriate fragment but no mutations in the other fragments.
The A24R-R2 virus contains an additional silent mutation. Toe targeted gene or gene fragment. Confluent dishes of BSC40 cells were infected
enome”) and the indicated PCR product. After a 4 day incubation at 37 °C in the
Table 1
Genotypes of error-prone PCR mutants
Virus Gene DNAa Protein a, b
G2R-R1 G2R T197C L66S
G2R-D1 G2R A303-; (A538G) fs 101, term 103; (I180V)
A24R-R1 A24R T1384C Y462H
A24R-R2 A24R (T2526A); A2650G (V842V); T884A
H5R-R1 H5R (A93T); A107T (N31K), D36V
a Irrelevant mutations are shown in parentheses.
b fs=frameshift; term=translation termination codon.
Fig. 3. Marker rescue of the H5R-R1 mutation. Confluent dishes of BSC40 cells
were infected with the Dts38 helper virus and co-transfected with wild-type
genomic DNA (“WT Genome”) and the indicated PCR product. After a 4 day
incubation at 37 °C in the presence of IBT, dishes were stained with crystal
violet.
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Fig. 3 was repeated using an agar overlay and a plaque was
picked from each of the G2R-R1, G2R-D1, A24R-R1, and
A24R-R2 transfections. Viruses in each picked plaque were
grown under IBT selection and plaque purified. DNA was
extracted from a viral lysate, and the gene targeted by error-
prone PCR was amplified and sequenced, confirming the
presence of the mutations reported in Table 1. These re-
constructed viruses were designated G2R-R1R, G2R-D1R,
A24R-R1R, and A24R-R2R.
The screen of several vaccinia virus genes for their potential
to give rise to IBT-resistant or IBT-dependent mutants identified
a number of genes with weak positive signals (Fig. 1). From
those genes with positive signals, three were chosen for further
study. These three genes (VLTF3 [A2L], rpo19 [A5R], and H5R)
were chosen because they encode proteins that differ from one
another with respect to their biochemical activities and known
roles in transcription. Of the three genes, H5R is of particular
interest due to its known association with the G2 elongation
factor (Black et al., 1998). In an attempt to isolate IBT-resistant
or IBT-dependent A2L, A5R, and H5R mutants, error-prone
PCR products amplified from a wild-type viral DNA template in
triplicate and corresponding to each of these three genes were
co-transfected with wild-type genomic DNA into Dts38 helper
infected cells in the presence of IBT. Each of the three H5R
transfections and one each of the A2L and A5R transfections
resulted in a cytopathic effect (CPE). Once the CPE was
complete, infected cell lysates were harvested. Viruses in these
lysates were plaque purified, grown, viral DNA was isolated,
and the gene targeted in the error-prone PCR (A2L, A5R, or
H5R) was PCR amplified and sequenced. The A2L-targeted
and A5R-targeted mutants each contained a silent mutation in
their targeted gene, while two of the three H5R-targeted mutants
contained the wild-type H5R sequence (data not shown). This
result indicates that the IBT resistance in these viruses arose via
spontaneous mutation at a locus other than the targeted locus.
However, the remaining H5R mutant, designated H5R-R1,
contains two missense mutations in H5R (Table 1), suggesting
that targeted mutation of H5R may have given rise to IBT
resistance.
To test whether the missense H5R mutations in H5R-R1
confer IBT resistance, a marker rescue experiment was done.
The H5R gene was amplified by high fidelity PCR using H5R-
R1 viral DNA as a template, and the amplified product was co-
transfected along with wild-type DNA into Dts38 helper virus
infected cells, and placed under selection for IBT resistance. Acontrol experiment using the A24R-2 DNA fragment from the
IBT-resistant mutant A24R-R1 was done in parallel. The results
are shown in Fig. 3. Transfections with H5R or A24R fragments
amplified from wild-type DNA yielded background levels of
plaque formation relative to uninfected, untransfected, or wild-
type genome transfected controls (Fig. 3, compare top row with
“WTA24R-2” or WT H5R”). Importantly, transfection with the
H5R fragment amplified from H5R-R1 yielded a significant
signal over this background, similar to the positive A24R gene
control (Fig. 3, compare “H5R-R1H5R”with “A24R-R1 A24R-
2”). Finally, a transfection with the H5R gene from H5R-R1
identical to the experiment shown in Fig. 3 was done using an
agar overlay so that IBT-resistant virus could be isolated and
characterized. Three plaques were picked, grown under IBT
selection, and plaque purified. The H5R gene from these three
viruses was sequenced. In two cases, the viruses contained both
the K31N and D36V mutations found in H5R-R1 (Table 1).
However, the H5R gene of the third virus contained only the
D36V mutation. The reconstructed virus containing this single
H5R mutation was designated H5R-R1R. Together these results
prove that the D36V mutation in the H5R gene confers IBT
resistance to vaccinia virus.
The viruses isolated by the error-prone PCR/marker rescue
strategy are capable of growth in the presence of IBT; however,
this observation does not distinguish between IBT-resistance
and IBT-dependence. In order to make such a distinction, a
plaque assay was done with each mutant using the IBT-sensitive
wild-type and the IBT-dependent G2A viruses as controls (Fig.
4). This experiment reveals that G2R-R1 is weakly IBT-
resistant, while G2R-D1 is IBT-dependent. The IBT depen-
Fig. 4. Plaque phenotypes of mutant viruses. Confluent monolayers of BSC40 cells in 6 cm dishes were infected with appropriate dilutions of WT virus and the
indicated mutants. The dishes were incubated at 37 °C for 6 days in the presence and absence of IBT prior to staining with crystal violet.
Fig. 5. Northern analysis of IBT-resistant mutant RNA. Confluent BSC40 cells
were infected with the indicated virus at m.o.i.=15 in the presence or absence of
IBTand incubated at 37 °C for 9 h. Total cellular RNAwas purified, fractionated
by gel electrophoresis, and transferred to a nylon membrane. The membrane was
probed with a riboprobe specific for the late A10L gene and exposed to film. The
virus used for infection is indicated at the top of the autoradiogram. The presence
of absence of IBT in the infection is indicated with a “+” or a “−” at the top of the
autoradiogram. Size markers are indicated at the left of the autoradiogram, in kb.
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genotype (Table 1). Importantly, the plaque assay also shows
that both of the A24R mutants and the H5R mutant are IBT-
resistant.
Phenotypic characterization of the A24R and H5R mutants
To gain insight into the mechanism of IBT resistance in the
newly isolated A24R and H5R mutants, postreplicative viral
mRNA synthesis was assessed using northern blot analysis.
Cells were infected with wt virus, the control IBT-resistant virus
IBTr90, or the reconstructed IBT-resistant mutant viruses A24R-
R1R, A24R-R2R, and H5R-R1R. RNA was isolated from
infected cells at 9 h post infection, fractionated by denaturing
agarose gel elctrophoresis, transferred to a nylon membrane,
and the blot was probed with a riboprobe specific for the late
A10L gene (Fig. 5). In the absence of IBT, the wt virus
infection revealed the heterogeneous population of transcripts
characteristic of postreplicative vaccinia RNAs. Viral RNAs
produced in the absence of IBT in the mutant infections were
indistinguishable from wt viral RNAs. In the presence of IBT,
wt transcripts reach a length sufficient to induce the 2–5 Å
pathway, resulting in RNA degradation revealed as a low
molecular weight smear in the northern blot (Pacha and Condit,
1985; Cohrs et al., 1989; Bayliss and Condit, 1993; Xiang,
1998). In the presence of IBT, all of the mutant infections
produce viral RNAs that were increased in length compared to
infections done in the absence of drug. The mutant infections
also produced apparently more viral RNA in the presence of
IBT compared to the infections done in the absence of drug.
This quantitative effect likely results from excess readthrough
into the A10L gene from upstream postreplicative genes. Con-
sistent with the northern analysis, rRNA visualized by ethidium
bromide staining of these same gels before transfer reveals
rRNA breakdown in wild-type infections done in the presence
of IBT, while in all other infections rRNA remained intact. In
summary, during infection with each of the viruses tested,
addition of IBT to the infections resulted in synthesis of
longer transcripts compared to infections done in the absence
of drug.
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Error-prone PCR coupled with marker rescue constitutes a
viable strategy for extending the number of known genes
involved in intermediate and late transcription elongation. This
was shown by the construction of IBT-resistant and IBT-depen-
dent mutants with random mutations in the specifically targeted
genes G2R, A24R, and H5R. While the G2R and A24R mutants
serve as a proof-of-concept, these IBT-resistant mutants addi-
tionally should prove useful for the study of the G2R and A24R
gene products themselves. Also, a screen of other potentially
interesting genes has uncovered several that warrant further
study. These include the small RNA polymerase subunit A5R
(rpo19), the intermediate initiation factors A8R and A23R, the
late initiation factors A1L and A2L, and the dsRNA-binding
protein E3L. Most importantly, a mutant mapping to the H5R
gene and capable of growth in the presence of IBT has been
identified. This result validates the error-prone PCR/marker
rescue approach for the screening of genes for their involve-
ment in transcription and provides strong genetic evidence toFig. 6. Structural modeling of A24-R1 and A24-R2. A model of the vaccinia rpo312
of S. cerevisiae RNA polymerase II subunit rpb2 (Prins et al., 2004). Yeast RNA poly
on the structure of the elongating yeast RNA polymerase. (A) Side (cutaway) view o
blue, the nontemplate DNA strand is in green, and the RNA is in red. Additional str
RNA polymerase II active site, with residues homologous to the A24R mutations h
residue to the 3′ end of the RNA, and in D, from the catalytic Mg++ to three conserve
(C and D) A24R-R2 (yeast T884). Colors indicate the following: mutant residue, ora
(A) is from Klug (2001).link H5R to the intermediate and late transcription control
system.
Interestingly, the previously characterized A24R IBT-resis-
tant mutant, IBTr90 (Condit et al., 1991; Prins et al., 2004) and
the new A24R-R1 mutant share the same genotype. Each has a
tyrosine to histidine substitution at position 462. This situation
is similar to that observed with the spontaneous mutants DL1-3
and DL10-7, which are an identical pair of rpo147 mutants
(Cresawn et al., 2007). These observations suggest that the
residues involved in these mutations may be critically important
for controlling elongation. They also suggest that there may a
relatively small number of possible polymerase mutations that
can lead to IBT-resistance.
A homology model of rpo132 previously constructed to
analyze spontaneous IBT-resistant mutants (Prins et al., 2004)
was used to approximate the location of the new A24R-R1 and
A24R-R2 mutations on the protein's structure (Fig. 6). As
noted above, IBTr90 and A24R-R1 have in common a single
point mutation (Y462H). According to our homology model,
Y462 in rpo132 is equivalent to L514 in yeast rpb2. This(gene A24R) subunit was constructed based on homology to the known structure
merase residues homologous to the mutant vaccinia alleles were then highlighted
f the RNA polymerase II transcribing complex. The template DNA strand is in
uctural features of the enzyme are indicated. (B–D) Close up views of the yeast
ighlighted in orange. The figures show distances in angstroms from the mutant
d active site aspartic acid residues and the mutation. (B) A24R-R1 (yeast L514).
nge; active site, purple; wall, grey; hybrid binding, green; RNA, red; DNA, blue
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implicated in maintaining the open conformation of the
downstream edge of the transcription bubble (Gnatt et al.,
2001). The Y462H mutation has been shown previously to
impede elongation by the mutant RNA polymerase in vitro
(Prins et al., 2004). Such an effect could theoretically
compensate for the elongation enhancing effects of IBT in
vivo. The A24R-R2 mutation affects residue T884 in rpo132,
which is equivalent to A981 in yeast rpb2. Thus the A24-R2
mutation is located in a region of the modeled polymerase
that is well-conserved between vaccinia and S. cerevisiae
RNA polymerase II. In the latter, this region interacts with the
DNA/RNA hybrid. Accordingly, we hypothesize that the
A24R-R2 mutation weakly destabilizes the DNA/RNA hybrid
by disrupting contacts with the polymerase. This model would
predict decreased transcriptional processivity, as has been
observed in other IBT-resistant mutants (Cresawn et al.,
2007).
The primary effect of IBT on a wt virus infection is to cause
synthesis of 3′ extended viral RNAs, theoretically either by
stimulating transcription elongation or by inhibiting transcrip-
tion termination. We have previously suggested two likely
mechanisms for IBT resistance: (1) inhibition of drug binding or
(2) compensation via decreased transcription elongation. North-
ern blot analysis revealed a phenotype for the A24R and H5R
IBT-resistant mutants that is identical to the phenotype
previously reported for IBT-resistant mutants in G2R and J6R
(rpo132; the second largest subunit of the viral RNA poly-
merase) (Cresawn et al., 2007). Specifically, all of the IBT-
resistant viruses responded to addition of IBT by synthesizing
viral RNAs that were increased in length relative to infections
done in the absence of drug. Therefore none of the mutants is
defective in drug binding. Based on these findings we propose
that the A24R and H5R mutants reported here are compensatory
mutants, that is, they are sufficiently elongation defective to
compensate for the effects of IBT, without at the same time
seriously compromising the infection done in the absence of
drug. The elongation defects are theoretically too subtle to be
detected by northern blotting, owing to the extreme hetero-
geneity of the postreplicative viral RNAs. In support of the
compensatory model, prior characterization of other IBT-
resistant mutants in the RNA polymerase, including IBTr90,
which has a genotype identical to A24-R1, has revealed trans-
cription elongation defects in vitro (Prins et al., 2004; Cresawn
et al., 2007). Ultimate proof of the compensatory model awaits
an in vitro assay for the presumed elongation activity of H5 and
other elongation factors, G2 and J3.
Isolation of an IBT-resistant mutant in the H5R gene, H5R-
R1, provides in vivo evidence linking the H5 protein to a role in
transcription elongation. Previous studies have implicated H5 in
awide variety of processes during viral infection. TheH5 protein
has a predicted molecular weight of 22 kDa, but runs ano-
malously at 34 kDa on SDS gels. H5 is a substrate for the
vaccinia virus coded B1 serine/threonine protein kinase and is
multiply phosphorylated in vivo (Beaud et al., 1995; Brown et
al., 2000; Beaud and Beaud, 2000; Boyle and Traktman, 2004).
The H5 protein is synthesized in abundance throughout infection(Rosel et al., 1986); at early times it is distributed diffusely
throughout the cytoplasm while at later times it is concentrated
into virosomes and is ultimately packaged into virions (Beaud
and Beaud, 1997; Murcia-Nicolas et al., 1999; Domi and Beaud,
2000). Biochemical experiments have implicated H5 in both
DNA replication and transcription. With respect to DNA
replication, H5 has been shown to interact with the DNA
polymerase processivity factor, A20, and with the B1 kinase,
which is required for DNA replication (McCraith et al., 2000).
With respect to transcription, H5 stimulates transcription from a
late viral promoter in vitro, and it has been shown to interact with
the late transcription factors VTLF-1 (G8) and VTLF-3 (A2),
and with the postreplicative transcription elongation factor G2
(Kovacs and Moss, 1996; Black et al., 1998; Dellis et al., 2004).
H5 also interacts with at least one other protein of unknown
function (McCraith et al., 2000). One temperature-sensitive
mutant in the H5R gene has previously been characterized;
interestingly, the mutant displays no detectable defects in viral
DNA replication or late gene expression, but instead displays a
severe defect in the earliest stages of morphogenesis (DeMasi
and Traktman, 2000). Our discovery of an H5 mutant with a
phenotype previously associated with G2R mutants (IBT-
resistance or IBT-dependence) is consistent with previously
reported biochemical experiments implicating H5 in late
transcription; it reinforces the significance of the G2–H5
interaction and suggests that H5 may either play a direct role
in transcription elongation or may influence G2 function in
transcription elongation in vivo.
Materials and methods
Cells and viruses; marker rescue; DNA sequencing; northern
blotting
Sources and handling of cells and viruses, and techniques for
marker rescue, DNA sequencing, and northern blotting are des-
cribed in the companion manuscript (Cresawn et al., 2007).
Agarose gels for the northern blots were run at 35 V for 17 h with
continuous recirculation of buffer.
Polymerase chain reaction
Isolation of DNA for use as a polymerase chain reaction
(PCR) template, and high fidelity PCR were performed as des-
cribed in the companion manuscript (Cresawn et al., 2007).
Error-prone PCR was performed in the same fashion, with three
exceptions: (1) Thermus aquaticus DNA polymerase was used
in place of Deep Vent DNA polymerase, (2) the final
concentration of dNTPs in the reaction mixture was unequal,
with ATP and GTP at a concentration of 100 μM and CTP and
TTP at a concentration of 500 μM, (3) MnCl2 was introduced
into the reaction mixture at a final concentration of 150 μM.
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